May 18, 2009
NeoCytex has been selected as a 2009 Tech 50 winner by TechJournal South. Tech 50 companies are the top innovative companies of tomorrow’s southeast region. Candidates are evaluated on technology innovation, management team, marketplace potential and execution success.

April 1, 2009
NeoCytex is awarded a $100,000 grant by the Kentucky Science and Technology Corporation for the project "Neuroreplacement Drug Therapy for Parkinson's Disease".

September 1, 2008
NeoCytex is awarded a $282,000 STTR grant by the National Institutes of Neurological Diseases and Stroke for the project "Small Molecule Drug Therapy for Parkinson's Disease".

July 1, 2008
NeoCytex is awarded $100,000 by the Kentucky Science and Technology Corporation to develop small molecule drug therapy for neurodegenerative diseases.

May 16, 2008
NeoCytex presentation at the Florida Venture Forum Early Stage Venture Capital Conference, Orlando.

April 21, 2008
"NeoCytex treatment may eventually help regrow brain cells" in TechJournal South.

September 26, 2007
NeoCytex is awarded a Phase I SBIR grant by the National Institute of Neurological Disorders and Stroke to develop "Small Molecule Drug Therapy for Stroke".

August 15-17, 2007
NeoCytex presentation at the MPI Research Summit: "Advances in Therapeutic Discovery and Development: Preclinical Cell-Based Therapy", Augusta, Michigan.

July 1, 2007
NeoCytex receives an award from the Kentucky Enterprise Fund to develop innovative new treatments for neurodegenerative diseases and stroke.

May 31, 2007
NeoCytex presentation at the Florida's Universities Tech Transfer Investor Forum, Miami, Florida.

February 22, 2007
NeoCytex presentation at iBio IndEx, organized by the Illinois Biotechnology Industry Organization, Chicago, Illinois.